OtherArticle
Functional impact of the G279S substitution in the adenosine A1-receptor (A1R-G279S), a mutation associated with Parkinson's disease
Shahrooz Nasrollahi-Shirazi, Daniel Szöllösi, Qiong Yang, Edin Muratspahic, Ali El-kasaby, Sonja Sucic, Thomas Stockner, Christian Nanoff and Michael Freissmuth
Molecular Pharmacology July 8, 2020, MOLPHARM-AR-2020-000003; DOI: https://doi.org/10.1124/molpharm.120.000003
Shahrooz Nasrollahi-Shirazi
1Pharmacology, Medical University of Vienna, Austria
Daniel Szöllösi
2Pharmacology, Medical University of Vienna
Qiong Yang
1Pharmacology, Medical University of Vienna, Austria
Edin Muratspahic
1Pharmacology, Medical University of Vienna, Austria
Ali El-kasaby
3Institute of Pharmacology, Medical University of Vienna, Austria
Sonja Sucic
3Institute of Pharmacology, Medical University of Vienna, Austria
Thomas Stockner
1Pharmacology, Medical University of Vienna, Austria
Christian Nanoff
4Medizinische Universität Wien, Austria
Michael Freissmuth
5Institute of Pharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, Austria
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
OtherArticle
A mutated A1-receptor associated with Parkinson's disease
Shahrooz Nasrollahi-Shirazi, Daniel Szöllösi, Qiong Yang, Edin Muratspahic, Ali El-kasaby, Sonja Sucic, Thomas Stockner, Christian Nanoff and Michael Freissmuth
Molecular Pharmacology July 8, 2020, MOLPHARM-AR-2020-000003; DOI: https://doi.org/10.1124/molpharm.120.000003
OtherArticle
A mutated A1-receptor associated with Parkinson's disease
Shahrooz Nasrollahi-Shirazi, Daniel Szöllösi, Qiong Yang, Edin Muratspahic, Ali El-kasaby, Sonja Sucic, Thomas Stockner, Christian Nanoff and Michael Freissmuth
Molecular Pharmacology July 8, 2020, MOLPHARM-AR-2020-000003; DOI: https://doi.org/10.1124/molpharm.120.000003
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement